415 - LONG-TERM SAFETY AND EFFICACY OF EVOLOCUMAB: A REVIEW OF RECENT DATA

Friday, October 28, 2022

6:00 PM – 6:20 PM EDT

Location: Canada Hall 2 East

Sponsored By

Target Audience: General: All cardiovascular (clinical and research) health professionals, Community cardiologists, Clinical cardiologists

Presenter(s)

Milan Gupta

Medical Director
Canadian Collaborative Research Network
University of Toronto, United States

Learning Objectives:

At the conclusion of this session, participants will be able to:

review the long-term safety and efficacy data for evolocumab;
share data recently presented at the ESC Meeting from the FOURIER outcomes open label extension study; and,
discuss the positive impact of this long term data for the management of lipids in Canadian ASCVD patients.

This session will focus on reviewing new data for evolocumab focused on long-term safety and efficacy, including recent data on the FOURIER outcomes open-label extension. The positive impact of this long-term data for the management of lipids in Canadian ASCVD patients in the future will be discussed